دورية أكاديمية

First-line mFOLFOX plus cetuximab followed by mFOLFOX plus cetuximab or single-agent cetuximab as maintenance therapy in patients with metastatic colorectal cancer: Phase II randomised MACRO2 TTD study

التفاصيل البيبلوغرافية
العنوان: First-line mFOLFOX plus cetuximab followed by mFOLFOX plus cetuximab or single-agent cetuximab as maintenance therapy in patients with metastatic colorectal cancer: Phase II randomised MACRO2 TTD study
المؤلفون: Aranda, E., García-Alfonso, P., Benavides, M., Sánchez Ruiz, A., Guillén-Ponce, C., Safont, M.J., Alcaide, J., Gómez, A., López, R., Manzano, J.L., Méndez Ureña, M., Sastre, J., Rivera, F., Grávalos, C., García, T., Martín-Valadés, J.I., Falcó, E., Navalón, M., González Flores, E., a<%2Fce%3Asup>+García+Tapiador%2C+A%2E%22">Ma<%2Fce%3Asup>+López+Muñoz%2C+A%2E%22">M